Diamondback Energy, Inc. MIDLAND, Texas, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Diamondback Energy, Inc. (NASDAQ: FANG) (“Diamondback” or the “Company”) today announced that it has entered into ...
Permian Basin-focused Diamondback Energy emerged as the region’s reigning independent producer giant a year ago following its $26 billion buyout of privately-held Endeavor Energy Resources.
Feb 20 (Reuters) - Diamondback Energy said on Thursday CEO Travis Stice intends to step down from his role after 13 years at the helm during the company's 2025 annual stockholders meeting and will ...
Diamondback to acquire Double Eagle IV assets for $3 billion in cash plus 6.9M million shares. Deal adds 40,000 acres in Midland Basin, boosting 2026+ FCF by 5%+. Get two weeks of free access to ...
(Reuters) - Diamondback Energy said on Tuesday it would buy certain units of EnCap Investments-backed energy producer Double Eagle for $4.08 billion in cash and stock, expanding its presence in ...
Diamondback Energy, Inc. FANG has secured key Midland Basin assets from Double Eagle IV Midco, LLC in a cash and stock deal. The deal enhances the company’s core holdings and positions it for ...
MIDLAND, Texas, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Diamondback Energy, Inc. (NASDAQ: FANG) ("Diamondback” or "the Company”) today announced that it has entered into a definitive purchase agreement to ...
Diamondback Energy, Inc., an independent oil and natural gas company, acquires, develops, explores, and exploits unconventional, onshore oil and natural gas reserves in the Permian Basin in West ...
As such, the Giants reveal both a franchise quarterback and a Dexter Lawrence sidekick in this 2025 mock draft. At this point, Sanders needs no introduction. The son of Deion Sanders and battery ...
This time, that asset is an All-Star. In De'Aaron Fox, the Spurs have landed a 27-year-old point guard capable of serving as Victor Wembanyama's sidekick as he attempts to lead the Spurs back into ...
Sidekick is also working with a number of other pharma companies on companion apps for drug therapies, including Pfizer in the area of atopic dermatitis and Bayer in peripheral artery disease.